Keyword: Harvard Medical School
The gift will enable Harvard to set up an incubator for biotech startups and invest in its research capabilities.
A rare cell type, discovered by two teams and named as "pulmonary ionocyte," appears to help drive cystic fibrosis.
Modifying tumor cells instead of immune cells from patients is showing promising results in animal models of breast and brain cancer.
A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.
Scientists at Dana-Farber Cancer Institute and Harvard have invented an immunotherapy “gel” that’s placed at the surgery site and is showing promising results in mouse models.
An improved understanding of dopamine release in the healthy brain could lead to better treatments for addiction.
A Stanford team aimed at host cells to fight flaviviruses, while Harvard scientists examined the longevity of Zika vaccines.
Biotech news over the last week included a reversible sealant to shore up eye injuries and a promising gene therapy for the immune disorder known as "bubble boy" disease.
Outcome Health has tapped Harvard Health Publications to improve and expand its health intelligence offerings.
Researchers at Boston Children’s Hospital have discovered an approach that could suppress a tumor’s growth by altering its metabolism.